Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Rooney MS"'
Autor:
Zoe R. Donaldson, Christine A. Denny, Ashley M. Cunningham, Tabia L Santos, Vanessa A. Gutzeit, Ahuna K, Rooney Ms
Social buffering occurs when the presence of a companion attenuates the physiological and/or behavioral effects of a stressful or fear-provoking event. It represents a way in which social interactions can immediately and potently modulate behavior. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f104addecff66a438e8ddfef25e8fc3
https://doi.org/10.1101/752386
https://doi.org/10.1101/752386
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Polansky MN; At the time this article was written, Maura N. Polansky was an associate professor at George Washington University in Washington, D.C. She now is a visiting clinical professor at the University of Illinois Chicago. J. Barton Gillum is program director and assistant professor in the post-baccalaureate premedicine program and PA program at George Washington University in Ashburn, Va. Maxwell S. Rooney was a research assistant at the time of this study and now is a student in the PA program at George Washington University. Jonathan Messing is program manager for the advanced practice provider transition into practice program at Inova Health System in Falls Church, Va., Gillum JB, Rooney MS, Messing J
Publikováno v:
JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2023 Jul 01; Vol. 36 (7), pp. 35-39.
Autor:
Awad MM; Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Govindan R; Washington University School of Medicine, St. Louis, MO, USA., Balogh KN; BioNTech US, Cambridge, MA, USA., Spigel DR; Tennessee Oncology, Nashville, TN, USA., Garon EB; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Bushway ME; BioNTech US, Cambridge, MA, USA., Poran A; BioNTech US, Cambridge, MA, USA., Sheen JH; BioNTech US, Cambridge, MA, USA., Kohler V; BioNTech US, Cambridge, MA, USA., Esaulova E; BioNTech US, Cambridge, MA, USA., Srouji J; BioNTech US, Cambridge, MA, USA., Ramesh S; BioNTech US, Cambridge, MA, USA., Vyasamneni R; BioNTech US, Cambridge, MA, USA., Karki B; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Sciuto TE; BioNTech US, Cambridge, MA, USA., Sethi H; Natera, Austin, TX, USA., Dong JZ; BioNTech US, Cambridge, MA, USA., Moles MA; BioNTech US, Cambridge, MA, USA., Manson K; BioNTech US, Cambridge, MA, USA., Rooney MS; BioNTech US, Cambridge, MA, USA., Khondker ZS; BioNTech US, Cambridge, MA, USA., DeMario M; BioNTech US, Cambridge, MA, USA., Gaynor RB; BioNTech US, Cambridge, MA, USA. Electronic address: richard.gaynor@biontech.us., Srinivasan L; BioNTech US, Cambridge, MA, USA. Electronic address: lakshmi.srinivasan1@external.biontech.us.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Sep 12; Vol. 40 (9), pp. 1010-1026.e11. Date of Electronic Publication: 2022 Aug 25.
Autor:
Choi J; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Goulding SP; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Conn BP; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., McGann CD; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Dietze JL; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Kohler J; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Lenkala D; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Boudot A; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Rothenberg DA; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Turcott PJ; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Srouji JR; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Foley KC; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Rooney MS; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., van Buuren MM; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Gaynor RB; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Abelin JG; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Addona TA; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Juneja VR; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA.
Publikováno v:
Cell reports methods [Cell Rep Methods] 2021 Sep 16; Vol. 1 (5), pp. 100084. Date of Electronic Publication: 2021 Sep 16 (Print Publication: 2021).
Autor:
Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, Chhangawala S, Rubinsteyn A, Hammerbacher J, Gaynor RB, Fritsch EF, Greshock J, Oslund RC, Barthelme D, Addona TA, Arieta CM, Rooney MS
Publikováno v:
Immunity [Immunity] 2021 Feb 09; Vol. 54 (2), pp. 388.
Autor:
Poran A; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Scherer J; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Bushway ME; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Besada R; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Balogh KN; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Wanamaker A; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Williams RG; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Prabhakara J; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Ott PA; Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Hu-Lieskovan S; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Khondker ZS; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Gaynor RB; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Rooney MS; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Srinivasan L; Neon Therapeutics/BioNTech US, Cambridge, MA, USA.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2020 Nov 17; Vol. 1 (8), pp. 100141. Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).
Autor:
Ott PA; Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA. Electronic address: patrick_ott@dfci.harvard.edu., Hu-Lieskovan S; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Chmielowski B; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Govindan R; Washington University School of Medicine, St. Louis, MO, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine, New York, NY, USA., Margolin K; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA., Awad MM; Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lin JJ; Cancer Center, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA., Friedlander T; Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA., Bushway ME; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Balogh KN; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Sciuto TE; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Kohler V; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Turnbull SJ; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Besada R; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Curran RR; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Trapp B; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Scherer J; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Poran A; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Harjanto D; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Barthelme D; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Ting YS; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Dong JZ; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Ware Y; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Huang Y; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Huang Z; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Wanamaker A; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Cleary LD; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Moles MA; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Manson K; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Greshock J; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Khondker ZS; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Fritsch E; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Rooney MS; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., DeMario M; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Gaynor RB; Neon Therapeutics/BioNTech US, Cambridge, MA, USA., Srinivasan L; Neon Therapeutics/BioNTech US, Cambridge, MA, USA. Electronic address: lakshmi.srinivasan@biontech.us.
Publikováno v:
Cell [Cell] 2020 Oct 15; Vol. 183 (2), pp. 347-362.e24.